Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Objective: To review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterise the effect of antiosteoporosis drug treatments on the risk of fractures acc...

Повний опис

Бібліографічні деталі
Автори: Händel, MN, Cardoso, I, von Bülow, C, Rohde, JF, Ussing, A, Nielsen, SM, Christensen, R, Body, J, Brandi, ML, Diez-Perez, A, Hadji, P, Javaid, MK, Lems, WF, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, SL, Langdahl, B, Abrahamsen, B
Формат: Journal article
Мова:English
Опубліковано: British Medical Journal Publishing Group 2023

Схожі ресурси

Схожі ресурси